Product Information

FEVERALL 325 MG SUPPOSITORY is a brand product labeled by Sun Pharmaceutical Industries Inc., priced at $0.9781 per EA under NDC 51672211602. Its NADAC has been published 324 times since Feb 18, 2015.

The High Outlier badge above means this manufacturer's average price in the Acetaminophen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

FEVERALL 325 MG SUPPOSITORY

Acetaminophen
$0.9781per EA
High Outlier
OTC

Strength

325 mg/1

NDC

51672211602

Classification

Brand

Dosage Form

SUPPOSITORY

Route

RECTAL

Last Updated

6/17/2026

Active Ingredients

ACETAMINOPHEN

Approval Type

New Drug (NDA)

FDA Application

NDA018337

On Market Since

12/12/2013

Price Statistics

The NADAC for FEVERALL 325 MG SUPPOSITORY has been published 324 times since Feb 18, 2015, and over the history we have for it it has risen 23.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9781 per EA
All-time high$0.9959 (Jan 14, 2026)
All-time low$0.6730 (Sep 18, 2024)
52-week high$0.9959
52-week low$0.8341
Median price$0.6977
Average price$0.7789
Largest weekly change+45.2% (Oct 2, 2024)
Weeks tracked324
Tracking sinceFeb 18, 2015

Price History

1W

0.0%

1M

-0.5%

3M

+1.3%

6M

-1.8%

1Y

+6.1%

3Y

+42.5%

5Y

+41.1%

All

+23.8%

Generic Alternatives

The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 98% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of FEVERALL 325 MG SUPPOSITORY?

The current National Average Drug Acquisition Cost (NADAC) for FEVERALL 325 MG SUPPOSITORY, manufactured by Sun Pharmaceutical Industries Inc., is $0.9781 per EA (NDC 51672211602), effective Jun 24, 2026.

How has the price of FEVERALL 325 MG SUPPOSITORY changed over time?

Over the history we have for it, the NADAC for FEVERALL 325 MG SUPPOSITORY has risen 23.8%. It has been tracked across 324 weekly CMS publications since Feb 18, 2015.

What are the highest and lowest recorded NADAC prices for FEVERALL 325 MG SUPPOSITORY?

Since Feb 18, 2015, the NADAC for FEVERALL 325 MG SUPPOSITORY has ranged from a low of $0.6730 (Sep 18, 2024) to a high of $0.9959 (Jan 14, 2026), with a median of $0.6977 per EA.

Are there cheaper alternatives to FEVERALL 325 MG SUPPOSITORY?

Yes. 9 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, QC PAIN RELIEF 325 MG TABLET, is $0.0232 per EA — about 98% below FEVERALL 325 MG SUPPOSITORY.

Who manufactures FEVERALL 325 MG SUPPOSITORY?

FEVERALL 325 MG SUPPOSITORY (NDC 51672211602) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a brand product.

Related Drugs

Same classification

No related drugs found.